Weill Cornell Medicine Pediatric Endocrinology researchers engage in a wide range of research activities to expand the understanding of endocrine disorders in children and adolescents, and to innovate more effective strategies for the prevention, management and resolution of endocrine disease. We continue to break new ground in our understanding of conditions including diabetes, congenital adrenal hyperplasia, pediatric growth and metabolism.
Both inadequate and excessive steroid supplementation in children with CAH may result in unwanted side effects during and after surgery. The goal of this study, led by Drs. Karen Su and Oksana Lekarev, is to measure clinical and biochemical parameters in children with CAH undergoing surgery, to assess the appropriateness of their steroid regimen during this critical period.
Children with diabetes have higher rates of depression, anxiety and other mental health comorbidities. This prospective study, led by Drs. Susan Samuels and Zoltan Antal, examines the incidence and impact of these conditions in children with Type 1 diabetes.
Weill Cornell Medicine is one of multiple institutions across the U.S. enrolling first- and second-degree relatives of children with Type 1 diabetes to screen for their own risk of developing Type 1 diabetes.
Adults who are prescribed Metformin are known to be at risk of developing vitamin B12 deficiency, but whether this risk is similar in children is unknown. Dr. Tiffany Schumaker leads this study to assess risk among children treated with Metformin.
Well-known side effects of antipsychotic medication are weight gain, Type 2 diabetes and other metabolic abnormalities. Led by Dr. Marisa Censani, this study evaluates various factors that may explain these side effects.
Dr. Alexis Feuer has previously identified and published data regarding the association between stimulant use and decreased bone mineral density in children. Dr. Feuer now leads basic science and translational studies to further understand the underlying cause of this association.
In collaboration with the pediatric hematology and oncology team at Weill Cornell Medicine, Dr. Zoltan Antal assesses the incidence of hyperglycemia in children newly diagnosed and treated for acute leukemia.